186 related articles for article (PubMed ID: 31176484)
1. The inhibition of trans-cinnamaldehyde on the virulence of Candida albicans via enhancing farnesol secretion with low potential for the development of resistance.
Ying L; Mingzhu S; Mingju Y; Ye X; Yuechen W; Ying C; Bing G; Hongchun L; Zuobin Z
Biochem Biophys Res Commun; 2019 Aug; 515(4):544-550. PubMed ID: 31176484
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of a maleimide compound on the virulence factors of
Li Y; Chen C; Cong L; Mao S; Shan M; Han Z; Mao J; Xie Z; Zhu Z
Virulence; 2023 Dec; 14(1):2230009. PubMed ID: 37367101
[TBL] [Abstract][Full Text] [Related]
3. Retigeric acid B attenuates the virulence of Candida albicans via inhibiting adenylyl cyclase activity targeted by enhanced farnesol production.
Chang W; Li Y; Zhang L; Cheng A; Lou H
PLoS One; 2012; 7(7):e41624. PubMed ID: 22848547
[TBL] [Abstract][Full Text] [Related]
4. Magnesium deprivation affects cellular circuitry involved in drug resistance and virulence in Candida albicans.
Hans S; Fatima Z; Hameed S
J Glob Antimicrob Resist; 2019 Jun; 17():263-275. PubMed ID: 30659981
[TBL] [Abstract][Full Text] [Related]
5. ANTIFUNGAL ACTIVITY OF CINNAMALDEHYDE AGAINST CANDIDA ALBICANS.
Pootong A; Norrapong B; Cowawintaweewat S
Southeast Asian J Trop Med Public Health; 2017 Jan; 48(1):150-8. PubMed ID: 29644831
[TBL] [Abstract][Full Text] [Related]
6. The possible molecular mechanisms of farnesol on the antifungal resistance of C. albicans biofilms: the regulation of CYR1 and PDE2.
Chen S; Xia J; Li C; Zuo L; Wei X
BMC Microbiol; 2018 Dec; 18(1):203. PubMed ID: 30509171
[TBL] [Abstract][Full Text] [Related]
7. The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model.
Bozó A; Domán M; Majoros L; Kardos G; Varga I; Kovács R
J Microbiol; 2016 Nov; 54(11):753-760. PubMed ID: 27796932
[TBL] [Abstract][Full Text] [Related]
8. Pravastatin inhibits farnesol production in Candida albicans and improves survival in a mouse model of systemic candidiasis.
Tashiro M; Kimura S; Tateda K; Saga T; Ohno A; Ishii Y; Izumikawa K; Tashiro T; Kohno S; Yamaguchi K
Med Mycol; 2012 May; 50(4):353-60. PubMed ID: 21954955
[TBL] [Abstract][Full Text] [Related]
9. Biatriosporin D displays anti-virulence activity through decreasing the intracellular cAMP levels.
Zhang M; Chang W; Shi H; Zhou Y; Zheng S; Li Y; Li L; Lou H
Toxicol Appl Pharmacol; 2017 May; 322():104-112. PubMed ID: 28286116
[TBL] [Abstract][Full Text] [Related]
10. Optimum Inhibition of Amphotericin-B-Resistant
Touil HFZ; Boucherit K; Boucherit-Otmani Z; Khoder G; Madkour M; Soliman SSM
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32098224
[No Abstract] [Full Text] [Related]
11. Bisbibenzyls, a new type of antifungal agent, inhibit morphogenesis switch and biofilm formation through upregulation of DPP3 in Candida albicans.
Zhang L; Chang W; Sun B; Groh M; Speicher A; Lou H
PLoS One; 2011; 6(12):e28953. PubMed ID: 22174935
[TBL] [Abstract][Full Text] [Related]
12. Transdermal administration of farnesol-ethosomes enhances the treatment of cutaneous candidiasis induced by
Shen T; Tian B; Liu W; Yang X; Sheng Q; Li M; Wang H; Wang X; Zhou H; Han Y; Ding C; Sai S
Microbiol Spectr; 2024 Apr; 12(4):e0424723. PubMed ID: 38415658
[TBL] [Abstract][Full Text] [Related]
13. Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans.
Navarathna DH; Hornby JM; Krishnan N; Parkhurst A; Duhamel GE; Nickerson KW
Infect Immun; 2007 Apr; 75(4):1609-18. PubMed ID: 17283095
[TBL] [Abstract][Full Text] [Related]
14.
Romo JA; Pierce CG; Esqueda M; Hung CY; Saville SP; Lopez-Ribot JL
Front Cell Infect Microbiol; 2018; 8():227. PubMed ID: 30042929
[TBL] [Abstract][Full Text] [Related]
15. In vitro inhibitory effects of farnesol and interactions between farnesol and antifungals against biofilms of Candida albicans resistant strains.
Xia J; Qian F; Xu W; Zhang Z; Wei X
Biofouling; 2017 Apr; 33(4):283-293. PubMed ID: 28317391
[TBL] [Abstract][Full Text] [Related]
16.
Dube Y; Khan A; Marimani M; Ahmad A
Can J Microbiol; 2020 Dec; 66(12):733-747. PubMed ID: 32777192
[TBL] [Abstract][Full Text] [Related]
17. Quercetin sensitizes fluconazole-resistant candida albicans to induce apoptotic cell death by modulating quorum sensing.
Singh BN; Upreti DK; Singh BR; Pandey G; Verma S; Roy S; Naqvi AH; Rawat AK
Antimicrob Agents Chemother; 2015 Apr; 59(4):2153-68. PubMed ID: 25645848
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Candida albicans biofilm and hyphae formation by biocompatible oligomers.
Lee JH; Kim YG; Lee J
Lett Appl Microbiol; 2018 Aug; 67(2):123-129. PubMed ID: 29885256
[TBL] [Abstract][Full Text] [Related]
19. Antibiofilm activity of certain phytocompounds and their synergy with fluconazole against Candida albicans biofilms.
Khan MS; Ahmad I
J Antimicrob Chemother; 2012 Mar; 67(3):618-21. PubMed ID: 22167241
[TBL] [Abstract][Full Text] [Related]
20. Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans.
Cui J; Ren B; Tong Y; Dai H; Zhang L
Virulence; 2015; 6(4):362-71. PubMed ID: 26048362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]